Users Coming Off Anti-Obesity Medications Gain Back Pounds Four Times Faster Compared to Dieters

Fresh analysis suggests that people who come off blockbuster slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise plans.

Research printed in a prominent medical journal points out that while obese individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of 0.8 kg per month upon discontinuation.

"Users using such drugs should be informed of the risk of rapid weight regain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery implies a return to original mass in about one and a half years.

Comparing Treatments

The analysis, which reviewed dozens of studies involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.

Researchers point out that people who lose weight through lifestyle changes alone usually have a more gradual creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Experts propose the mode of action of the injections is key to understanding the accelerated rebound.

The injections copy a natural hormone called GLP-1, which controls hunger.

"Long-term administration of the hormone levels far above than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating far more likely."

An Ongoing Issue?

Medical guidelines advise the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts say that, due to the likelihood of weight regain, the treatment should be considered ongoing.

This view is reinforced by drug manufacturers, who state that the findings "underscore the chronic nature of excess weight," similar to managing diseases like diabetes.

Patient Accounts

Users who have discontinued the jabs report a powerful return of appetite.

"I experienced a switch flipping and you become extremely hungry," described an individual.

The struggle is compounded if individuals have not developed permanent lifestyle or habit changes during therapy.

Significant Adoption

Figures show that millions of people in the UK have tried these injections in the last 12 months, with interest remaining high.

• Use is higher among women compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the drugs through private healthcare rather than public health services.

Finally, researchers caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic cure and maintained weight loss relies on ongoing lifestyle support.